WPG Advisers’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
AIM
WPG Advisers's BIIB Position: Q2 2026 in Review
WPG Advisers increased its Biogen (BIIB) stake by 25% in Q2 2026, buying an estimated $8.99K and bringing the position to 236 shares worth $51K. The position accounts for 0.03% of the portfolio, ranked #305.
WPG Advisers first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- WPG Advisers held 236 shares of Biogen worth $51K as of Q2 2026.
- WPG Advisers bought 47 Biogen shares in Q2 2026, an estimated $8.99K.
- Biogen made up 0.03% of WPG Advisers's portfolio in Q2 2026, its #305 holding.
- WPG Advisers first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
- 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.